98 related articles for article (PubMed ID: 34614540)
1. Visual inspection with acetic acid screening for cervical cancer among women receiving anti-retroviral therapy for human immunodeficiency virus infection in northern Tanzania.
Chinn JO; Runge AS; Dinicu AI; Chang J; Maher JA; Crawford EW; Naaseh A; Cooper EC; Zezoff DC; White KM; Lucas AN; Bera KR; Bernstein M; Hari A; Ziogas A; Tewari SE; Pearre DC; Tewari KS
J Obstet Gynaecol Res; 2021 Dec; 47(12):4365-4370. PubMed ID: 34614540
[TBL] [Abstract][Full Text] [Related]
2. Implementation of human papillomavirus video education for women participating in mass cervical cancer screening in Tanzania.
Cooper EC; Maher JA; Naaseh A; Crawford EW; Chinn JO; Runge AS; Lucas AN; Zezoff DC; Bera KR; Dinicu AI; White KM; Tewari SE; Hari A; Bernstein M; Chang J; Ziogas A; Pearre DC; Tewari KS
Am J Obstet Gynecol; 2021 Jan; 224(1):105.e1-105.e9. PubMed ID: 32682861
[TBL] [Abstract][Full Text] [Related]
3. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.
Baldur-Felskov B; Mwaiselage J; Faber MT; Kjaerem M; de la Cour CD; Munk C; Kahesa C; Iftner T; Rasch V; Kjaer SK
Trop Med Int Health; 2019 Feb; 24(2):229-237. PubMed ID: 30444556
[TBL] [Abstract][Full Text] [Related]
5. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
6. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
7. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy.
Chung MH; McKenzie KP; De Vuyst H; Richardson BA; Rana F; Pamnani R; Njoroge JW; Nyongesa-Malava E; Sakr SR; John-Stewart GC; Mugo NR
AIDS; 2013 Nov; 27(18):2909-19. PubMed ID: 23842133
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV Status.
Anderson J; Wysong M; Estep D; Besana G; Kibwana S; Varallo J; Sun K; Lu E
PLoS One; 2015; 10(9):e0139242. PubMed ID: 26405784
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.
Joseph J; Demke O; Ameyan L; Bitilinyu-Bango J; Bourgoin B; Diop M; Guèye B; Kama J; Lubega M; Madzima B; Maparo T; Mhizha T; Musoke A; Nabadda S; Phiri T; Tchereni T; Wiwa O; Hariharan K; Peter T; Khan S
BMJ Open; 2023 Jan; 13(1):e065074. PubMed ID: 36609331
[TBL] [Abstract][Full Text] [Related]
11. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
12. Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana.
Ramogola-Masire D; Grover S; Mathoma A; Monare B; Gabaitiri L; Bazzett-Matabele L; Hofmeyr G; Morroni C; Luckett R
BMC Womens Health; 2022 Apr; 22(1):100. PubMed ID: 35366863
[TBL] [Abstract][Full Text] [Related]
13. Unraveling cervical cancer screening dilemmas: histopathological insights from VIA and LEEP at bugando medical centre, Mwanza.
Kaizilege GK; Ndaboine E; Chuma C; Mujuni F; Kiritta R; Matovelo D; Ottoman O; Elias E; Masalu N; Kidenya BR; Mazigo HD
BMC Cancer; 2024 Jan; 24(1):66. PubMed ID: 38216912
[TBL] [Abstract][Full Text] [Related]
14. Tanzanian women´s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 - 2019.
Henke A; Kluge U; Borde T; Mchome B; Serventi F; Henke O
Glob Health Action; 2021 Jan; 14(1):1852780. PubMed ID: 33371824
[No Abstract] [Full Text] [Related]
15. Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
Hall MT; Simms KT; Murray JM; Keane A; Nguyen DTN; Caruana M; Lui G; Kelly H; Eckert LO; Santesso N; de Sanjose S; Swai EE; Rangaraj A; Owiredu MN; Gauvreau C; Demke O; Basu P; Arbyn M; Dalal S; Broutet N; Canfell K
Nat Med; 2023 Dec; 29(12):3059-3066. PubMed ID: 38087116
[TBL] [Abstract][Full Text] [Related]
16. Distribution of cervical abnormalities detected by visual inspection with acetic acid in Swaziland, 2011-2014: A retrospective study.
Ginindza TG; Almonte M; Dlamini X; Sartorius B
Afr J Prim Health Care Fam Med; 2018 Oct; 10(1):e1-e7. PubMed ID: 30456977
[TBL] [Abstract][Full Text] [Related]
17. Association of HIV status and treatment characteristics with VIA screening outcomes in Malawi: A retrospective analysis.
Lewis S; Mphande M; Chibwana F; Gumbo T; Banda BA; Sigauke H; Moses A; Gupta S; Hoffman RM; Moucheraud C
PLoS One; 2022; 17(1):e0262904. PubMed ID: 35077501
[TBL] [Abstract][Full Text] [Related]
18. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
20. Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province.
Moon TD; Silva-Matos C; Cordoso A; Baptista AJ; Sidat M; Vermund SH
J Int AIDS Soc; 2012 Jun; 15(2):17406. PubMed ID: 22713260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
